Rallybio (RLYB) Financials: Revenue & Earnings

RLYB price $16.06 +0.13 +0.82%

Ticker
RLYB
Price
$16.06
Change
+0.13 +0.82%
Market cap ?
$85.32M
P/E ?
3.50
Forward P/E ?
4.10
Dividend yield ?
0.00%
Beta ?
-0.85
Sector
Healthcare
Industry
Biotechnology

Financials

2019202020212022202320242025
00000636000858000

Rallybio Corporation is a clinical-stage biotechnology firm dedicated to discovering and bringing to market transformative therapies for individuals facing severe and uncommon illnesses. Its most advanced therapeutic candidate, RLYB212, is a monoclonal anti-HPA-1a antibody currently undergoing Phase II clinical trials. This candidate, along with RLYB211, is aimed at preventing fetal and neonatal alloimmune…

Fair value

RLYB fair value $80.30. Price $16.06. Price is 80% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 212.74K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.00%. Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 5.31M. Net debt -31.20M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare RLYB

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-03-11—-1.60——
2026-10-27-0.48-1.44——
2026-08-06-1.09-1.28——
2026-05-13-1.46-1.20212.00K212.00K
2026-03-12-1.11-1.24222.00K100.00K
2025-11-06-2.84-1.71212.00K66.67K
2025-08-07-1.76-1.96212.00K66.67K
2025-05-08-1.68-1.68212.00K13.33K
2025-03-13-2.00-2.1638.00K149.50K
2024-11-07-2.08-2.82299.00K75.00K
2024-08-08-2.96-2.99299.00K—
2024-05-09-3.76-2.99—166.67K
2024-03-12-4.00-3.52——
2023-11-09-3.60-0.51——
2023-08-08-3.68-0.48——
2023-05-09-3.44-0.49——
2023-03-06-3.68-0.63——
2022-11-07-4.80-0.54——
2022-08-08-4.56-0.59——
2022-05-10-3.84-0.45——
2022-03-15-3.36-0.39——
2021-11-10-2.96-7.12——
2021-09-09-2.88-4.31——
2021-03-31-4.77———
2020-12-31-3.78———
2020-09-30-2.57———
2020-06-30-1.76———
2020-03-31-1.40———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Irregular.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2026-11-06$13.562026-11-052026-11-13Irregular

Insider trades

DateInsiderActionSharesPriceValue
2026-10-16Soteropoulos PaulaBuy3.56K$2.388.48K
2026-10-16Soteropoulos PaulaSell3.56K$2.388.48K
2026-10-16Boudreau Helen MBuy2.06K$15.2831.51K
2026-10-16Boudreau Helen MSell2.06K$15.2831.51K
2026-10-12Hopfner Robert LorneBuy2.06K$15.2831.51K
2026-10-12Hopfner Robert LorneBuy3.56K$2.388.48K
2026-10-12Hopfner Robert LorneBuy9.20K$7.6069.89K
2026-10-12Hopfner Robert LorneSell3.56K$2.388.48K
2026-10-12Hopfner Robert LorneSell9.20K$7.6069.89K
2026-10-12Hopfner Robert LorneSell2.06K$15.2831.51K
2026-10-09Lieber Jonathan IBuy3.91K$6.0823.77K
2026-10-09Lieber Jonathan ISell3.91K$6.0823.77K
2026-10-06Uden StephenBuy22.46K$6.08136.53K
2026-10-06Uden StephenSell22.46K$6.08136.53K
2026-09-29Lieber Jonathan IBuy5.00K$6.0830.40K
2026-09-29Lieber Jonathan ISell5.00K$6.0830.40K
2026-09-24Liu HuiBuy8.48K$7.6064.46K
2026-09-24Liu HuiBuy3.56K$2.388.48K
2026-09-24Liu HuiSell3.56K$2.388.48K
2026-09-24Liu HuiSell8.48K$7.6064.46K
2026-09-16Chung WendyBuy3.56K$2.388.48K
2026-09-16Chung WendySell3.56K$2.388.48K
2026-07-06Boudreau Helen MBuy3.56K$2.388.48K
2026-07-06Boudreau Helen MSell3.56K$2.388.48K
2026-05-19ADAR1 Capital Management, LLCBuy200$13.802.76K
2026-05-19ADAR1 Capital Management, LLCBuy10.00K$13.98139.82K
2026-05-18ADAR1 Capital Management, LLCBuy6.01K$13.9883.98K
2026-05-15ADAR1 Capital Management, LLCBuy200$13.952.79K
2026-05-15ADAR1 Capital Management, LLCBuy100$13.801.38K
2026-05-13ADAR1 Capital Management, LLCBuy75.18K$14.001.05M
2026-05-13ADAR1 Capital Management, LLCBuy4.08K$13.8056.31K
2026-05-12ADAR1 Capital Management, LLCBuy800$13.8311.06K
2026-05-11ADAR1 Capital Management, LLCBuy19.90K$14.00278.60K
2026-05-11ADAR1 Capital Management, LLCBuy25.00K$14.00350.00K
2026-05-11ADAR1 Capital Management, LLCBuy5.10K$14.0071.39K
2026-05-05ADAR1 Capital Management, LLCBuy35.10K$14.00491.26K
2026-05-04ADAR1 Capital Management, LLCBuy116.90K$13.971.63M
2026-05-04ADAR1 Capital Management, LLCBuy3.90K$13.9054.20K
2026-05-04ADAR1 Capital Management, LLCOther0——
2026-03-04FMR LLCOther0——
2026-02-23Lieber Jonathan ISell789$5.063.99K
2026-02-18Lieber Jonathan IBuy2.50K——
2026-02-18MACKAY MARTINBuy18.05K$4.4580.34K
2026-02-18HUNT RONALDBuy14.30K$4.4563.66K
2025-05-13Boudreau Helen MBuy28.50K$0.308.55K
2025-05-13Chung WendyBuy28.50K$0.308.55K
2025-05-13HUNT RONALDBuy28.50K$0.308.55K
2025-05-13Nash Christine ABuy28.50K$0.308.55K
2025-05-13Hopfner Robert LorneBuy28.50K$0.308.55K
2025-05-13Soteropoulos PaulaBuy28.50K$0.308.55K
2025-05-13Liu HuiBuy28.50K$0.308.55K
2025-05-13MACKAY MARTINBuy28.50K$0.308.55K
2025-02-14Uden StephenBuy453.70K$0.76344.81K
2025-02-14Ryder StevenBuy180.00K$0.76136.80K
2025-02-14Lieber Jonathan IBuy180.00K$0.76136.80K
2025-01-02MACKAY MARTINBuy92.86K$0.9588.21K
2025-01-02HUNT RONALDBuy73.57K$0.9569.89K
2025-01-02Hopfner Robert LorneBuy73.57K$0.9569.89K
2025-01-02Liu HuiBuy67.86K$0.9564.46K
2024-05-15HUNT RONALDBuy16.50K$1.9131.52K
2024-05-15Boudreau Helen MBuy16.50K$1.9131.52K
2024-05-15Liu HuiBuy16.50K$1.9131.52K
2024-05-15PARMAR KUSHBuy16.50K$1.9131.52K
2024-05-15Soteropoulos PaulaBuy16.50K$1.9131.52K
2024-05-15Nash Christine ABuy16.50K$1.9131.52K
2024-05-15Hopfner Robert LorneBuy16.50K$1.9131.52K
2024-05-15Chung WendyBuy16.50K$1.9131.52K
2024-02-15Uden StephenBuy216.00K$1.86401.76K
2024-02-15MACKAY MARTINBuy216.00K$1.86401.76K
2024-02-15Lieber Jonathan IBuy120.00K$1.86223.20K
2024-02-15Ryder StevenBuy120.00K$1.86223.20K
2024-01-02PARMAR KUSHBuy27.12K$2.4065.08K
2024-01-02HUNT RONALDBuy29.10K$2.4069.83K
2023-05-17PARMAR KUSHBuy15.49K$5.6487.36K
2023-05-17Nash Christine ABuy15.49K$5.6487.36K
2023-05-17Boudreau Helen MBuy15.49K$5.6487.36K
2023-05-17Hopfner Robert LorneBuy15.49K$5.6487.36K
2023-05-17Soteropoulos PaulaBuy15.49K$5.6487.36K
2023-05-17Liu HuiBuy15.49K$5.6487.36K
2023-05-17HUNT RONALDBuy15.49K$5.6487.36K
2023-05-17Chung WendyBuy12.35K$5.6469.67K
2023-03-14Lieber Jonathan IBuy5.00K$5.2126.05K
2023-03-07PARMAR KUSHSell100.00K$8.20820.00K
2023-03-075AM Partners V, LLCSell100.00K$8.20820.00K
2023-02-06Uden StephenBuy214.00K$6.501.39M
2023-02-06Ryder StevenBuy119.00K$6.50773.50K
2023-02-06MACKAY MARTINBuy214.00K$6.501.39M
2023-02-01Lieber Jonathan IBuy240.00K$6.811.63M
2023-02-01Lieber Jonathan IOther0——
2023-01-03Liu HuiBuy10.24K——
2023-01-03PARMAR KUSHBuy10.34K——
2023-01-03Chung WendyBuy9.48K——
2023-01-03HUNT RONALDBuy11.10K——
2022-11-15VIKING GLOBAL INVESTORS LPBuy3.33M$6.0020.00M
2022-08-01Chung WendyBuy26.88K——
2022-08-01Chung WendyOther0——
2022-06-03PARMAR KUSHSell99.67K$12.501.25M
2022-06-035AM Opportunities I, L.P.Sell99.67K$12.501.25M
2022-06-03ROCKLAGE SCOTT MSell99.67K$12.501.25M
2022-06-035AM Opportunities I, L.P.Sell50.33K$12.50629.11K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 38, holders 0 vs prior quarter. Ownership 71.35%.

HolderSharesChangeChange %Value
ADAR1 CAPITAL MANAGEMENT, LLC926.35K905.82K+4411.09%14.82M
FMR LLC794.72K794.72KNew12.72M
VIKING GLOBAL INVESTORS LP524.35K524.35KNew8.39M
TPG GP A, LLC378.55K378.55KNew6.06M
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC300.58K300.58KNew4.81M
RENAISSANCE TECHNOLOGIES LLC199.91K199.91KNew3.20M
NANTAHALA CAPITAL MANAGEMENT, LLC188.42K-112.21K-37.33%3.01M
VANGUARD CAPITAL MANAGEMENT LLC172.50K60.46K+53.96%2.76M
ALMITAS CAPITAL LLC120.68K120.68KNew1.93M
RANGELEY CAPITAL, LLC104.85K104.85KNew1.68M
CITADEL ADVISORS LLC72.20K72.20KNew1.16M
MARINER, LLC50.57K50.57KNew809.06K
JANE STREET GROUP, LLC47.42K47.42KNew758.77K
GEODE CAPITAL MANAGEMENT, LLC32.05K32.05KNew512.87K
BLACKROCK, INC.30.33K30.33KNew485.31K
HRT FINANCIAL LP25.66K25.66KNew410.00K
XTX TOPCO LTD21.50K21.50KNew343.95K
VANGUARD FIDUCIARY TRUST CO16.82K3.27K+24.16%269.12K
TWO SIGMA INVESTMENTS, LP16.62K16.62KNew265.90K
STATE STREET CORP13.00K13.00KNew207.94K
QUADRATURE CAPITAL LTD12.99K12.99KNew207.92K
DIMENSIONAL FUND ADVISORS LP11.28K00.00%180.48K
VANGUARD GLOBAL ADVISERS, LLC1.44K00.00%23.07K
MERCER GLOBAL ADVISORS INC /ADV1.25K1.25KNew20.00K
HARTFORD FINANCIAL MANAGEMENT INC.812812New12.99K

Earnings and financials

Rallybio Corporation (RLYB) trades at $16.06, with a market cap of $85.32M and a trailing P/E of 3.50. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
00000636000858000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Rallybio (RLYB) Financials: Revenue & Earnings

RLYB$16.06+0.13 +0.82%

$85.32M

Market Cap

3.50

P/E

4.10

Forward P/E

—

Score

Price History